April 27, 2010 — While repair of large abdominal aortic aneurysms (AAA's) is well accepted, randomized clinical trials have failed to demonstrate benefit for early surgical repair of small aneurysms over surveillance, according to researchers from New York-Presbyterian Hospital in New York.
April 28, 2010 — The U.S. District Court in Minnesota this week declined to accept the plea agreement between Guidant and the U.S. Justice Department related to its failure to report adverse events from its implantable cardioverter defibrillators (ICDs) in 2005. Boston Scientific acquired Guidant after the incident.
May 4, 2010 — Including a coronary artery calcium score in a risk assessment for future heart disease events — such as heart attacks — provides a better estimate in some populations than a standard coronary risk factors assessment, according to research supported by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH).
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 4, 2010 — New research released this week in the Journal of the American College of Cardiology shows the value of implantable cardiac device diagnostics in identifying worsening heart failure.
May 4, 2010 – The U.S. District Court in New Hampshire is being asked this week to review and reverse a jury verdict on patent litigation involving two companies with competing hemostasis management technology used in the cath lab.
May 4, 2010 – A deal has been struck to produce a generic version of Merck & Company’s Zetia (ezetimibe). In the United States, the cholesterol modifying agent has annual U.S. sales of about $1.4 billion, according to IMS Health data.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 4, 2010 - Currently, using conventional imaging modalities to distinguish between acute and chronic aortic dissection (AD) for surgical risk evaluation is not possible. However, in a recent study, researchers were able to use fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) to detect reparatory hypermetabolism in the lacerated aortic wall of acute AD.
May 3, 2010 – Two new ambulatory electrocardiogram (ECG) devices are being introduced this week to help speed diagnostics and workflow. Midmark Corp. and Mortara partnered to create the systems.
May 3, 2010 – Excellent safety and clinical outcomes were shown in patients ages 70 and older who received a stent using endothelial progenitor cell capture technology. The stent accelerates the natural healing process of the vessel wall after stent implantation.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 3, 2010 – A point-of-care ultrasound system for use by emergency medical services (EMS) is being developed in collaboration between SonoSite Inc. and Physio-Control Inc. Under the terms of the agreement, the Physio-Control sales organization will assist in introducing SonoSite’s products to the EMS market.
Several paclitaxel drug-eluting balloons (DEBs) are currently available on the European market, and several others are in development. There are currently no DEBs available in the United States.
Drug-eluting balloons (DEBs) may offer new options in treating peripheral vessels and restenosis. DEBs already offer an alternative treatment tool in Europe, and the first DEB clinical trial in the United States is expected to begin later this year.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
In recent years, many medical device companies saw the underserved lower extremity as an opportunity to enter the market for peripheral artery disease (PAD) treatments. For this reason, device innovation and clinical trials in this segment have been robust.
April 29, 2010 - Merge Healthcare announced today it completed the acquisition of Amicas Inc., in which Merge purchased all of the outstanding shares of Amicas common stock for $6.05 per share. To finance the transaction, Merge placed $200 million senior secured notes due 2015, and completed a private placement of preferred and common stock of $41.75 million.
April 28, 2010 - A national "CT Dose Summit" will bring together leading experts on medical imaging to lay the foundation for establishing guidelines for performing computed tomography (CT) scans.